FDA Approves COVID Antiviral Pills

(Silver Spring, MD) — The FDA is giving the green light to the COVID-19 pills. The drug from Pfizer will be prescribed for use in adults and children ages 12 and up with mild to moderate COVID who are at risk for severe disease or hospitalization. Clinical trials showed Pfizer’s pill, called Paxlovid, reduced hospitalization rates by 89-percent if taken within three days of the onset of symptoms.